Literature DB >> 15963708

Virulence factors, pathogenesis and vaccine protection in cholera and ETEC diarrhea.

Joaquín Sánchez1, Jan Holmgren.   

Abstract

Recent work has provided new insights into the pathogenesis of the potentially life-threatening diarrheas caused by Vibrio cholerae and enterotoxigenic Escherichia coli (ETEC): a new mechanism (post-translational degradation), which is involved in the control of cholera toxin expression, has been discovered. Recent evidence also suggests that vibrios upregulate cholera toxin expression in response to intestinal fluid components, and enterotoxin-carrying bacterial outer membrane vesicles might have a function in ETEC pathogenesis. An important role of the environment is supported by the correlation between cholera incidence and elevated sea surface temperature, which supports the notion that the zooplankton is a V. cholerae reservoir. Additionally, environmental lytic cholera phages could influence cholera seasonality by 'terminating' the seasonal epidemic. Finally, the strong herd immunity elicited by an oral cholera vaccine indicates that cholera vaccination could have a significant public health impact.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15963708     DOI: 10.1016/j.coi.2005.06.007

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  45 in total

1.  Engineered bacterial communication prevents Vibrio cholerae virulence in an infant mouse model.

Authors:  Faping Duan; John C March
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

2.  Expression of Escherichia coli virulence usher protein attenuates wild-type Salmonella.

Authors:  Xinghong Yang; Zhiyong Suo; Theresa Thornburg; Kathryn Holderness; Ling Cao; Timothy Lim; Nancy Walters; Laura Kellerman; Linda Loetterle; Recep Avci; David W Pascual
Journal:  Virulence       Date:  2012-01-01       Impact factor: 5.882

Review 3.  Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni.

Authors:  Miguel O'Ryan; Roberto Vidal; Felipe del Canto; Juan Carlos Salazar; David Montero
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 4.  Maximizing protection from use of oral cholera vaccines in developing country settings: an immunological review of oral cholera vaccines.

Authors:  Sachin N Desai; Alejandro Cravioto; Dipika Sur; Suman Kanungo
Journal:  Hum Vaccin Immunother       Date:  2014-05-26       Impact factor: 3.452

5.  Assembly of CS1 pili: the role of specific residues of the major pilin, CooA.

Authors:  Angela M Starks; Barbara J Froehlich; Tamara N Jones; June R Scott
Journal:  J Bacteriol       Date:  2006-01       Impact factor: 3.490

6.  Vibrio cholerae O395 outer membrane vesicles modulate intestinal epithelial cells in a NOD1 protein-dependent manner and induce dendritic cell-mediated Th2/Th17 cell responses.

Authors:  Debashree Chatterjee; Keya Chaudhuri
Journal:  J Biol Chem       Date:  2012-12-28       Impact factor: 5.157

7.  Review of Climate Change and Health in Ethiopia: Status and Gap Analysis.

Authors:  Belay Simane; Hunachew Beyene; Wakgari Deressa; Abera Kumie; Kiros Berhane; Jonathan Samet
Journal:  Ethiop J Health Dev       Date:  2016       Impact factor: 0.725

Review 8.  Current state and challenges in developing oral vaccines.

Authors:  Julia E Vela Ramirez; Lindsey A Sharpe; Nicholas A Peppas
Journal:  Adv Drug Deliv Rev       Date:  2017-04-22       Impact factor: 15.470

Review 9.  Immune mechanisms of protection: can adjuvants rise to the challenge?

Authors:  Amy S McKee; Megan K L MacLeod; John W Kappler; Philippa Marrack
Journal:  BMC Biol       Date:  2010-04-12       Impact factor: 7.431

10.  On the origins of a Vibrio species.

Authors:  Tammi Vesth; Trudy M Wassenaar; Peter F Hallin; Lars Snipen; Karin Lagesen; David W Ussery
Journal:  Microb Ecol       Date:  2010-01       Impact factor: 4.552

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.